These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 39103070

  • 1. MicroRNA-522-3p promotes brain metastasis in non-small cell lung cancer by targeting Tensin 1 and modulating blood-brain barrier permeability.
    Liu Q, Bao H, Zhang S, Li C, Sun G, Sun X, Fu T, Wang Y, Liang P.
    Exp Cell Res; 2024 Sep 01; 442(1):114199. PubMed ID: 39103070
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR.
    J Hematol Oncol; 2017 Jun 19; 10(1):125. PubMed ID: 28629431
    [Abstract] [Full Text] [Related]

  • 3. miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8.
    Li C, Zheng H, Xiong J, Huang Y, Li H, Jin H, Ai S, Wang Y, Su T, Sun G, Xiao X, Fu T, Wang Y, Gao X, Liang P.
    Cell Death Dis; 2022 Aug 12; 13(8):699. PubMed ID: 35961957
    [Abstract] [Full Text] [Related]

  • 4. TGF-β1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p/EPB41L5 axis to promote non-small cell lung cancer brain metastasis.
    Wu D, Deng S, Li L, Liu T, Zhang T, Li J, Yu Y, Xu Y.
    Cell Death Dis; 2021 Jul 20; 12(8):721. PubMed ID: 34285192
    [Abstract] [Full Text] [Related]

  • 5. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX, Zhou KC, Cao Y.
    Mol Cancer; 2014 Nov 06; 13():245. PubMed ID: 25373388
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C.
    J Exp Clin Cancer Res; 2016 May 10; 35():76. PubMed ID: 27164951
    [Abstract] [Full Text] [Related]

  • 7. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L, Chen D, Song J.
    Thorac Cancer; 2020 Mar 10; 11(3):603-611. PubMed ID: 31953899
    [Abstract] [Full Text] [Related]

  • 8. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W, Zhang Y, Xia S.
    Thorac Cancer; 2020 Mar 10; 11(3):549-560. PubMed ID: 31923353
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q, Ran P, Zhang X, Guo X, Yuan Y, Dong T, Zhu B, Zheng S, Xiao C.
    Cell Physiol Biochem; 2018 Mar 10; 50(3):987-1004. PubMed ID: 30355927
    [Abstract] [Full Text] [Related]

  • 10. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X, Liu D, Peng G, Liu J, Yang H.
    Comput Math Methods Med; 2022 Mar 10; 2022():4597087. PubMed ID: 35126623
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
    Wei C, Zhang R, Cai Q, Gao X, Tong F, Dong J, Hu Y, Wu G, Dong X.
    Aging (Albany NY); 2019 Sep 08; 11(17):6734-6761. PubMed ID: 31498117
    [Abstract] [Full Text] [Related]

  • 12. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
    Liao XH, Xie Z, Guan CN.
    Neoplasma; 2018 Sep 19; 65(5):673-682. PubMed ID: 30249107
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G, Li L.
    Biomed Pharmacother; 2020 Jun 19; 126():110100. PubMed ID: 32197208
    [Abstract] [Full Text] [Related]

  • 14. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z, Yin J, Peng G, Long X.
    Anticancer Drugs; 2021 Jan 01; 32(1):1-10. PubMed ID: 32932275
    [Abstract] [Full Text] [Related]

  • 15. LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1.
    Shen Q, Sun Y, Xu S.
    Respir Res; 2020 Sep 16; 21(1):235. PubMed ID: 32938459
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K, Jiang Y, Xiang X, Gong Q, Zhou C, Zhang L, Ma Q, Zhuang L.
    Thorac Cancer; 2020 May 16; 11(5):1180-1190. PubMed ID: 32147945
    [Abstract] [Full Text] [Related]

  • 17. Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.
    Li S, Niu X, Li H, Liang Y, Sun Z, Yan Y.
    Cell Cycle; 2019 Dec 16; 18(24):3525-3539. PubMed ID: 31736412
    [Abstract] [Full Text] [Related]

  • 18. Circ_0028826 Promotes Growth and Metastasis of NSCLC via Acting as a Sponge of miR-758-3p to Derepress IDH2 Expression.
    Guo L, Liu X, Zhang J, Liu Z, Zhang B, Sun Y, Cui D, Liu J.
    Clin Respir J; 2024 Aug 16; 18(8):e13802. PubMed ID: 39113352
    [Abstract] [Full Text] [Related]

  • 19. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y, Zhao L, Li Q, Xi C, Li Y, Li Z.
    Thorac Cancer; 2020 Aug 16; 11(8):2196-2208. PubMed ID: 32602212
    [Abstract] [Full Text] [Related]

  • 20. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y, Wu X, Jin J, Man W, Li J, Li X, Li Y, Yao H, Zhong R, Chen S, Wu J, Zhu T, Lin Y, Xu J, Wang Y.
    Mol Cancer; 2023 Nov 06; 22(1):179. PubMed ID: 37932766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.